People · Operator

Reza Kazemipour

Named in public records as an officer, director or promoter · active 2018–2018 · Other Health Care

1
Companies
1
Filings
$44.7M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Scanadu IncOther Health CareSeries B$44.7M$71.9M2018
Operator network

Reza Kazemipour at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

David King · 16 companies · 1 sharedDavid KingKevin Talbot · 9 companies · 1 sharedKevin TalbotGerard Van Hamel Platerink · 6 companies · 1 sharedGerard Van Hamel …Robert Harrington · 3 companies · 1 sharedRobert HarringtonScott Bonham · 2 companies · 1 sharedScott BonhamWalter De Brouwer · 2 companies · 1 sharedWalter De BrouwerBob Gardner · 1 companies · 1 sharedBob GardnerDaya Ranamukhaarachchi · 1 companies · 1 sharedDaya Ranamukhaara…Ezra Kucharz · 1 companies · 1 sharedEzra KucharzJackie Schneider · 1 companies · 1 sharedJackie SchneiderJaime Tenedorio · 1 companies · 1 sharedJaime TenedorioJamie Tenedorio · 1 companies · 1 sharedJamie TenedorioSam De Brouwer · 1 companies · 1 sharedSam De BrouwerSriram Vaidyanathan · 1 companies · 1 sharedSriram Vaidyanath…Scanadu Inc · $44.7M raisedScanadu IncReza KazemipourRK
Reza Kazemipour Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Reza Kazemipour on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
David King116
Kevin Talbot19
Gerard Van Hamel Platerink16
Robert Harrington13
Scott Bonham12
Walter De Brouwer12
Jackie Schneider11
Sriram Vaidyanathan11
Jaime Tenedorio11
Bob Gardner11
Sam De Brouwer11
Jamie Tenedorio11
Daya Ranamukhaarachchi11
Ezra Kucharz11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.